Article
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.
The American journal of cardiology - 1 Sept 2014
Biagini Elena, Olivotto Iacopo, Iascone Maria, Parodi Maria I, Girolami Francesca, Frisso Giulia, Autore Camillo, Limongelli Giuseppe, Cecconi Massimiliano, Maron Barry J, Maron Martin S, Rosmini Stefania, Formisano Francesco, Musumeci Beatrice, Cecchi Franco, Iacovoni Attilio, Haas Tammy S, Bacchi Reggiani Maria L, Ferrazzi Paolo, Salvatore Francesco, Spirito Paolo, Rapezzi Claudio
Abstract excerpt
End-stage hypertrophic cardiomyopathy (ES-HC) has an ominous prognosis. Whether genotype can influence ES-HC occurrence is unresolved. We assessed the spectrum and clinical correlates of HC-associated mutations in a large multicenter cohort with end-stage ES-HC. Sequencing analysis of 8 sarcomere genes (MYH7, MYBPC3, TNNI3, TNNT2, TPM1, MYL2, MYL3, and ACTC1) and 2 metabolic genes (PRKAG2 and LAMP2) was performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
